Jupiter Total Current Liabilities from 2010 to 2024
| JUNS Stock | USD 9.73 1.13 10.41% |
Total Current Liabilities | First Reported 2010-12-31 | Previous Quarter 5.8 M | Current Value 6.3 M | Quarterly Volatility 973.7 K |
Check Jupiter Neurosciences, financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Jupiter Neurosciences,'s main balance sheet or income statement drivers, such as Interest Expense of 298.9 K, Selling General Administrative of 2.8 M or Total Revenue of 199.5 K, as well as many indicators such as Price To Sales Ratio of 533, Dividend Yield of 0.0 or Days Sales Outstanding of 32.73. Jupiter financial statements analysis is a perfect complement when working with Jupiter Neurosciences, Valuation or Volatility modules.
Jupiter | Total Current Liabilities |
Latest Jupiter Neurosciences,'s Total Current Liabilities Growth Pattern
Below is the plot of the Total Current Liabilities of Jupiter Neurosciences, Common over the last few years. Total Current Liabilities is an item on Jupiter Neurosciences, balance sheet that include short term debt, accounts payable, accrued salaries payable, payroll taxes payable, accrued liabilities and other debts. Total Current Liabilities of Jupiter Neurosciences, Common are important to investors because some useful performance ratios such as Current Ratio and Quick Ratio require Total Current Liabilities to be accurate. It is the total amount of liabilities that a company is expected to pay within one year, including debts, accounts payable, and other short-term financial obligations. Jupiter Neurosciences,'s Total Current Liabilities historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Jupiter Neurosciences,'s overall financial position and show how it may be relating to other accounts over time.
| Total Current Liabilities | 10 Years Trend |
|
Total Current Liabilities |
| Timeline |
Jupiter Total Current Liabilities Regression Statistics
| Arithmetic Mean | 4,793,427 | |
| Geometric Mean | 4,714,715 | |
| Coefficient Of Variation | 20.31 | |
| Mean Deviation | 780,951 | |
| Median | 4,260,961 | |
| Standard Deviation | 973,706 | |
| Sample Variance | 948.1B | |
| Range | 3M | |
| R-Value | 0.72 | |
| Mean Square Error | 485.8B | |
| R-Squared | 0.52 | |
| Significance | 0 | |
| Slope | 157,643 | |
| Total Sum of Squares | 13.3T |
Jupiter Total Current Liabilities History
About Jupiter Neurosciences, Financial Statements
Jupiter Neurosciences, shareholders use historical fundamental indicators, such as Total Current Liabilities, to determine how well the company is positioned to perform in the future. Although Jupiter Neurosciences, investors may analyze each financial statement separately, they are all interrelated. The changes in Jupiter Neurosciences,'s assets and liabilities, for example, are also reflected in the revenues and expenses on on Jupiter Neurosciences,'s income statement. Understanding these patterns can help investors time the market effectively. Please read more on our fundamental analysis page.
| Last Reported | Projected for Next Year | ||
| Total Current Liabilities | 5.8 M | 6.3 M |
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Jupiter Stock Analysis
When running Jupiter Neurosciences,'s price analysis, check to measure Jupiter Neurosciences,'s market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Jupiter Neurosciences, is operating at the current time. Most of Jupiter Neurosciences,'s value examination focuses on studying past and present price action to predict the probability of Jupiter Neurosciences,'s future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Jupiter Neurosciences,'s price. Additionally, you may evaluate how the addition of Jupiter Neurosciences, to your portfolios can decrease your overall portfolio volatility.